JPCYS Logo
Back to all stories
Genesys Bio LogoHealthcare & Biotech

Biotech Leader Cuts Healthcare Cyber Risk Exposure by 91% Across R&D Networks

Highlight: 91% Risk Cut
Continuous autonomous control monitoring across patient data networks to meet HIPAA, GDPR, and GxP standards without slowing software deployments.

The Challenge

Prior to partnering with us, the organization struggled with manual evidence collection, disjointed security tooling, and an overwhelming compliance burden that slowed down engineering and deployment times. Audit preparation alone took several months of back-and-forth, and control drift was a persistent issue due to the sheer volume of continuously changing multi-cloud assets.

The Solution

By deploying our continuous autonomous operating system, they were able to unify their disparate compliance frameworks and security posture into a single, real-time pane of glass. Automated continuous monitoring entirely replaced traditional point-in-time spreadsheet checks, ensuring that any drift in critical controls was identified, alerted, and remediated autonomously.

Key Outcomes

  • Instant notification & auto-remediation of control failures
  • Unified HIPAA & GDPR compliance scorecard across 8 global labs
  • Saved $850k annually in third-party auditor retainers

Tags

#HIPAA#GDPR#GxP